Charlotte E. Ariyan

21.0k total citations · 5 hit papers
100 papers, 6.1k citations indexed

About

Charlotte E. Ariyan is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Charlotte E. Ariyan has authored 100 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Oncology, 29 papers in Immunology and 27 papers in Molecular Biology. Recurrent topics in Charlotte E. Ariyan's work include Cutaneous Melanoma Detection and Management (46 papers), CAR-T cell therapy research (31 papers) and Immunotherapy and Immune Responses (22 papers). Charlotte E. Ariyan is often cited by papers focused on Cutaneous Melanoma Detection and Management (46 papers), CAR-T cell therapy research (31 papers) and Immunotherapy and Immune Responses (22 papers). Charlotte E. Ariyan collaborates with scholars based in United States, Australia and United Kingdom. Charlotte E. Ariyan's co-authors include Kitt Falk Petersen, Douglas E. Befroy, Gerald I. Shulman, Gary W. Cline, Sylvie Dufour, Loretta DiPietro, James Dziura, Douglas L. Rothman, Daniel G. Coit and Phillip Görden and has published in prestigious journals such as Science, Cell and Journal of Clinical Investigation.

In The Last Decade

Charlotte E. Ariyan

97 papers receiving 6.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance

2003 1.7k citations Kitt Falk Petersen, Douglas E. Befroy et al. profile →
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

2002 581 citations Kitt Falk Petersen, Elif A Oral et al. Journal of Clinical Investigation profile →
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

2002 503 citations Kitt Falk Petersen, Elif A Oral et al. Journal of Clinical Investigation profile →
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido

2011 410 citations Charlotte E. Ariyan, Jianda Yuan et al. profile →
Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity

2019 374 citations Charlotte E. Ariyan et al. profile →

Peers

Charlotte E. Ariyan

MB

ONCOL

PHYSI

EPIDE

IMMUN

Vance B. Matthews Australia

Carmen Guerra Spain

Brenda R. Kwak Switzerland

Richard Palmqvist Sweden

Yasushi Shintani Japan

Yasushi Fukushima Japan

Bruno Esposito France

Zsuzsanna K. Zsengellér United States

Yuzo Kodama Japan

Yoshiji Yamada Japan

Vance B. Matthews Australia

Charlotte E. Ariyan

1.5k ×0.8

MB

1.5k ×0.8

ONCOL

704 ×0.4

PHYSI

770 ×0.6

EPIDE

1.2k ×0.9

IMMUN

Citations per year, relative to Charlotte E. Ariyan Charlotte E. Ariyan (= 1×) peers Vance B. Matthews

Countries citing papers authored by Charlotte E. Ariyan

Since Specialization

Citations

This map shows the geographic impact of Charlotte E. Ariyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte E. Ariyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte E. Ariyan more than expected).

Fields of papers citing papers by Charlotte E. Ariyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte E. Ariyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte E. Ariyan. The network helps show where Charlotte E. Ariyan may publish in the future.

Co-authorship network of co-authors of Charlotte E. Ariyan

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte E. Ariyan. A scholar is included among the top collaborators of Charlotte E. Ariyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte E. Ariyan. Charlotte E. Ariyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Bartlett, Edmund K., Nigel P. Barker, Charlotte E. Ariyan, et al.. (2025). Outcomes of Patients Undergoing Sentinel Lymph Node Biopsy for Merkel Cell Carcinoma. Annals of Surgical Oncology.

2.

Akkooi, Alexander C. J. van, Charlotte E. Ariyan, & Marc Moncrieff. (2025). Melanoma Great Debate: Targeted Versus Complete Nodal Dissection Following Neoadjuvant Therapy for Melanoma: Is it Time to Push Forward or Hold Off on Continued De-Escalation of Surgery?. Annals of Surgical Oncology. 32(12). 8930–8936. 1 indexed citations

3.

Frosina, Denise, et al.. (2024). In Situ Protein Expression Analysis of Melanocyte Differentiation Antigen TRP1 (Tyrosinase-Related Protein-1). American Journal of Dermatopathology. 46(9). 563–571. 2 indexed citations

4.

Burton, Elizabeth M., Khalida Wani, Denái R. Milton, et al.. (2024). Biomarker analysis and updated clinical outcomes: Neoadjuvant systemic treatment (NST) with nivolumab (nivo) and relatlimab (rela) in surgically resectable melanoma.. Journal of Clinical Oncology. 42(16_suppl). 9587–9587.

5.

Choo, Zi-Ning, Julie M. Behr, Aditya Deshpande, et al.. (2023). Most large structural variants in cancer genomes can be detected without long reads. Nature Genetics. 55(12). 2139–2148. 16 indexed citations

6.

Flynn, Jessica, Katherine S. Panageas, Armin Shahrokni, et al.. (2021). Assessment of Frailty Can Guide Decision Making for Utilization of Sentinel Lymph Node Biopsy in Patients with Thick Melanoma. Annals of Surgical Oncology. 28(13). 9031–9038. 4 indexed citations

7.

Janjigian, Yelena Y., Jedd D. Wolchok, & Charlotte E. Ariyan. (2021). Eradicating micrometastases with immune checkpoint blockade: Strike while the iron is hot. Cancer Cell. 39(6). 738–742. 23 indexed citations

8.

Bartlett, Edmund K., Ann Y. Lee, Philip M. Spanheimer, et al.. (2020). Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma. British journal of surgery. 107(11). 1480–1488. 9 indexed citations

9.

Bartlett, Edmund K., Jessica Flynn, Katherine S. Panageas, et al.. (2019). High neutrophil‐to‐lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD‐1 inhibitor monotherapy. Cancer. 126(1). 76–85. 104 indexed citations

10.

Karakousis, Giorgos C. & Charlotte E. Ariyan. (2017). An Update on Randomized Clinical Trials in Melanoma. Surgical Oncology Clinics of North America. 26(4). 559–586. 1 indexed citations

11.

Callahan, Margaret K., Gregg Masters, Christine A. Pratilas, et al.. (2013). Paradoxical Activation of T Cells via Augmented ERK Signaling Mediated by a RAF Inhibitor. Cancer Immunology Research. 2(1). 70–79. 91 indexed citations

12.

Gyorki, David, Jianda Yuan, Zhenyu Mu, et al.. (2013). Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma. Annals of Surgical Oncology. 20(9). 3106–3111. 42 indexed citations

13.

Karakousis, Giorgos C., Neeta Pandit‐Taskar, Meier Hsu, et al.. (2012). Prognostic significance of drainage to pelvic nodes at sentinel lymph node mapping in patients with extremity melanoma. Melanoma Research. 23(1). 40–46. 7 indexed citations

14.

Plitas, George & Charlotte E. Ariyan. (2012). Controversies in the Management of Regional Nodes in Melanoma. Journal of the National Comprehensive Cancer Network. 10(3). 414–421. 4 indexed citations

15.

Kingham, T. Peter, Katherine S. Panageas, Charlotte E. Ariyan, et al.. (2009). Outcome of Patients with a Positive Sentinel Lymph Node who do not Undergo Completion Lymphadenectomy. Annals of Surgical Oncology. 17(2). 514–520. 57 indexed citations

16.

Salvalaggio, Paolo R. O., Geoffrey Camirand, Charlotte E. Ariyan, et al.. (2006). Antigen Exposure during Enhanced CTLA-4 Expression Promotes Allograft Tolerance In Vivo. The Journal of Immunology. 176(4). 2292–2298. 23 indexed citations

17.

Ariyan, Stephan, et al.. (2004). Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma 1. Journal of the American College of Surgeons. 198(6). 924–932. 26 indexed citations

18.

Ariyan, Charlotte E., Paolo Salvalaggio, Songyan Deng, et al.. (2003). Cutting Edge: Transplantation Tolerance through Enhanced CTLA-4 Expression. The Journal of Immunology. 171(11). 5673–5677. 60 indexed citations

19.

Petersen, Kitt Falk, Elif A Oral, Sylvie Dufour, et al.. (2002). Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. Journal of Clinical Investigation. 109(10). 1345–1350. 44 indexed citations

20.

Petersen, Kitt Falk, Elif A Oral, Sylvie Dufour, et al.. (2002). Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. Journal of Clinical Investigation. 109(10). 1345–1350. 503 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact